Activation of CD3/TCR negative human thymocytes via CD28 molecule

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We have observed that the CD28 molecule was present on the cell surface of a large fraction of resting CD3- thymocytes (40 to 100%). Interestingly, the majority (>90%) of surface CD3-CD28- cells reacted in the cytoplasm with anti-CD28 (CK248, 9.3) and anti-CD3ε chain mAbs (Leu4, OKT3). Along this line, we found that CD28 surface expression could be induced within 18 hr on CD3-CD28- thymocytes using very low doses of phorbol-13-myristate-12-acetate (PMA). This event was accompanied by the appearance of CD25 and CD69 activation antigens but not of CD3/TCR complex. These results were further confirmed by immunoprecipitation studies. It is noteworthy that the T-cell activation pathway initiated via the CD28 molecule is functional in resting CD3- thymocytes in the presence of PMA and/or IL2. Finally, stimulation of CD3- immature thymocytes via CD28 gave rise to a large fraction (about one-third) of CD3-CD8+ cells.

Original languageEnglish
Pages (from-to)105-112
Number of pages8
JournalCellular Immunology
Volume136
Issue number1
DOIs
Publication statusPublished - 1991

Fingerprint

Thymocytes
Acetates
T-Cell Antigen Receptor-CD3 Complex
Muromonab-CD3
Immunoprecipitation
Interleukin-2
Cytoplasm
T-Lymphocytes
phorbol-12-myristate

ASJC Scopus subject areas

  • Cell Biology
  • Immunology

Cite this

Activation of CD3/TCR negative human thymocytes via CD28 molecule. / Raffaella Zocchi, M.; Poggi, Alessandro.

In: Cellular Immunology, Vol. 136, No. 1, 1991, p. 105-112.

Research output: Contribution to journalArticle

@article{2c7f5a97aa8241418e5173a1eb94ba63,
title = "Activation of CD3/TCR negative human thymocytes via CD28 molecule",
abstract = "We have observed that the CD28 molecule was present on the cell surface of a large fraction of resting CD3- thymocytes (40 to 100{\%}). Interestingly, the majority (>90{\%}) of surface CD3-CD28- cells reacted in the cytoplasm with anti-CD28 (CK248, 9.3) and anti-CD3ε chain mAbs (Leu4, OKT3). Along this line, we found that CD28 surface expression could be induced within 18 hr on CD3-CD28- thymocytes using very low doses of phorbol-13-myristate-12-acetate (PMA). This event was accompanied by the appearance of CD25 and CD69 activation antigens but not of CD3/TCR complex. These results were further confirmed by immunoprecipitation studies. It is noteworthy that the T-cell activation pathway initiated via the CD28 molecule is functional in resting CD3- thymocytes in the presence of PMA and/or IL2. Finally, stimulation of CD3- immature thymocytes via CD28 gave rise to a large fraction (about one-third) of CD3-CD8+ cells.",
author = "{Raffaella Zocchi}, M. and Alessandro Poggi",
year = "1991",
doi = "10.1016/0008-8749(91)90385-O",
language = "English",
volume = "136",
pages = "105--112",
journal = "Cellular Immunology",
issn = "0008-8749",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Activation of CD3/TCR negative human thymocytes via CD28 molecule

AU - Raffaella Zocchi, M.

AU - Poggi, Alessandro

PY - 1991

Y1 - 1991

N2 - We have observed that the CD28 molecule was present on the cell surface of a large fraction of resting CD3- thymocytes (40 to 100%). Interestingly, the majority (>90%) of surface CD3-CD28- cells reacted in the cytoplasm with anti-CD28 (CK248, 9.3) and anti-CD3ε chain mAbs (Leu4, OKT3). Along this line, we found that CD28 surface expression could be induced within 18 hr on CD3-CD28- thymocytes using very low doses of phorbol-13-myristate-12-acetate (PMA). This event was accompanied by the appearance of CD25 and CD69 activation antigens but not of CD3/TCR complex. These results were further confirmed by immunoprecipitation studies. It is noteworthy that the T-cell activation pathway initiated via the CD28 molecule is functional in resting CD3- thymocytes in the presence of PMA and/or IL2. Finally, stimulation of CD3- immature thymocytes via CD28 gave rise to a large fraction (about one-third) of CD3-CD8+ cells.

AB - We have observed that the CD28 molecule was present on the cell surface of a large fraction of resting CD3- thymocytes (40 to 100%). Interestingly, the majority (>90%) of surface CD3-CD28- cells reacted in the cytoplasm with anti-CD28 (CK248, 9.3) and anti-CD3ε chain mAbs (Leu4, OKT3). Along this line, we found that CD28 surface expression could be induced within 18 hr on CD3-CD28- thymocytes using very low doses of phorbol-13-myristate-12-acetate (PMA). This event was accompanied by the appearance of CD25 and CD69 activation antigens but not of CD3/TCR complex. These results were further confirmed by immunoprecipitation studies. It is noteworthy that the T-cell activation pathway initiated via the CD28 molecule is functional in resting CD3- thymocytes in the presence of PMA and/or IL2. Finally, stimulation of CD3- immature thymocytes via CD28 gave rise to a large fraction (about one-third) of CD3-CD8+ cells.

UR - http://www.scopus.com/inward/record.url?scp=0025873861&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025873861&partnerID=8YFLogxK

U2 - 10.1016/0008-8749(91)90385-O

DO - 10.1016/0008-8749(91)90385-O

M3 - Article

C2 - 1647880

AN - SCOPUS:0025873861

VL - 136

SP - 105

EP - 112

JO - Cellular Immunology

JF - Cellular Immunology

SN - 0008-8749

IS - 1

ER -